Sepimostat

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSepimostat
Drug Alias Name司匹司他sepimostat瑟莫司他sepimostatumTO-187 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptide hydrolase inhibitors
TargetsPeptide hydrolase
Therapy Area/IndicationsEsophagitis, Peptic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTorii Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTorii Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsEsophagitis, Peptic

Other Information

ATC CodeN/A
Related LinksN/A